FTISADTSK acetate
FTISADTSK acetate is a stable signature peptide derived from Trastuzumab, suitable for quantification via selected reaction monitoring (SRM) . It serves as a critical analytical standard in pharmacokinetic and bioanalytical studies, supporting both in vitro and in vivo research on therapeutic antibody monitoring.
Product Specifications
Field of Research
Metabolism Research
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog